|
|
||||||||



* Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215;
Division of Immunology, Transplant Research Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and
Gruppo di ImmunoEndocrinologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche, Napoli, Italy
Leptin has direct effects not only on neuroendocrine function and metabolism, but also on T cell-mediated immunity. We report in this study that leptin receptor (ObR) is expressed on resting normal mouse CD4+, CD8+, B cells, and monocyte/macrophages. ObR expression is up-regulated following cell activation, but with different kinetics, in different lymphocyte subsets. Leptin binding to ObR results in increased STAT-3 activation in T cells, with a different activation pattern in resting vs anti-CD3 Ab stimulated T cells. Leptin also promotes lymphocyte survival in vitro by suppressing Fas-mediated apoptosis. B lymphocytes appear to be more susceptible to the antiapoptotic effects of leptin, and they show higher surface expression of ObR, compared with T cells. Moreover, CD4+ T cells isolated from ObR-deficient mice displayed a reduced proliferative response, compared with normal controls. Furthermore, ObR/STAT-3-mediated signaling in T lymphocytes is decreased in the diet-induced obese mouse model of obesity and leptin resistance. In summary, our findings show that the ObR is expressed on normal mouse lymphocyte subsets, that leptin plays a role in lymphocyte survival, and that leptin alters the ObR/STAT-3-mediated signaling in T cells. Taken together, our data further support the notion that nutritional status acting via leptin-dependent mechanisms may alter the nature and vigor of the immune response.
This article has been cited by other articles:
![]() |
N. P. Hyland, A. P. Chambers, C. M. Keenan, Q. J. Pittman, and K. A. Sharkey Differential adipokine response in genetically predisposed lean and obese rats during inflammation: a role in modulating experimental colitis? Am J Physiol Gastrointest Liver Physiol, November 1, 2009; 297(5): G869 - G877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L Gruver, M. S Ventevogel, and G. D Sempowski Leptin receptor is expressed in thymus medulla and leptin protects against thymic remodeling during endotoxemia-induced thymus involution J. Endocrinol., October 1, 2009; 203(1): 75 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bluher and C. S Mantzoros Leptin in humans: lessons from translational research Am. J. Clinical Nutrition, March 1, 2009; 89(3): 991S - 997S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. AGUILAR-CHAVEZ, J. I. GAMEZ-NAVA, M. A. LOPEZ-OLIVO, S. GALVAN-MELENDRES, E. G. CORONA-SANCHEZ, C. A. LOAIZA-CARDENAS, A. CELIS, E. G. CARDONA-MUNOZ, and L. GONZALEZ-LOPEZ Circulating Leptin and Bone Mineral Density in Rheumatoid Arthritis J Rheumatol, March 1, 2009; 36(3): 512 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. MacIver, S. R. Jacobs, H. L. Wieman, J. A. Wofford, J. L. Coloff, and J. C. Rathmell Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival J. Leukoc. Biol., October 1, 2008; 84(4): 949 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Musaad and E. N. Haynes Biomarkers of Obesity and Subsequent Cardiovascular Events Epidemiol. Rev., May 10, 2007; (2007) mxm005v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Smith, P. A. Sheridan, J. B. Harp, and M. A. Beck Diet-Induced Obese Mice Have Increased Mortality and Altered Immune Responses When Infected with Influenza Virus J. Nutr., May 1, 2007; 137(5): 1236 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Macia, M. Delacre, G. Abboud, T.-S. Ouk, A. Delanoye, C. Verwaerde, P. Saule, and I. Wolowczuk Impairment of Dendritic Cell Functionality and Steady-State Number in Obese Mice J. Immunol., November 1, 2006; 177(9): 5997 - 6006. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |